COMP <GO>
ENSG vs HCA // EV/EBITDA & P/E VALUATION
The Ensign Group Inc. (NASDAQ) VS. HCA Healthcare Inc. (NYSE) • 15-METRIC TALLY: ENSG 2
— HCA 10
▲ EV/EBITDA & P/E VALUATION LEADER: HCA
LAST: $179.06 (-1.35%) • MKT CAP: $10.59B
valuation
17.0x
LAST: $467.73 (-1.15%) • MKT CAP: $98.85B
valuation
11.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENSG VS. HCA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ENSG | HCA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.00% | 18.90% | -0.90 | HCA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 17.0x | 11.5x | +5.50 | HCA | /valuation <GO> |
| Free Cash Flow Yield | 3.11% | 7.43% | -4.32 | HCA | /fcf-yield <GO> |
| Operating Margin | 8.50% | 10.90% | -2.40 | HCA | /operating-margins <GO> |
| Net Profit Margin | 6.80% | 9.00% | -2.20 | HCA | /net-margins <GO> |
| Revenue Growth (YoY) | 18.80% | 7.10% | +11.70 | ENSG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.13% | 0.66% | -0.53 | HCA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.73 | 3.68 | +0.05 | ENSG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 59.2 | -5.10 | HCA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 1.04 | -0.15 | HCA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 14.2x | +12.30 | HCA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.59B | $98.85B | -$88.26B | HCA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ENSG REV | HCA REV | ENSG GROSS % | HCA GROSS % | ENSG FCF | HCA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.03B | $75.60B | 20.1% | — | $337.8M | $7.69B |
| FY 2024 | $4.24B | $70.60B | 20.3% | — | $156.5M | $5.64B |
| FY 2023 | $3.71B | $64.97B | — | — | $209.8M | $6.51B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENSG // BETA 0.89
HCA // BETA 1.04